The WireSafe™ for Preventing Retained Central Venous Catheter Guidewires: Clinical Usability

Mariyaselvam, Maryanne; Pearson, Darcy; Heij, Robin; Fawzy, Emad; Young, Peter

doi:10.1007/978-3-319-94373-2_27

Cited by 2 publications

(1 citation statement)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Novel improvements in device technology may further solve the issue. The National Health Service of the United Kingdom implemented WireSafe™ (Venner Medical Technologies, Singapore) following its regulatory approval, which is a locked procedure pack engineered to eliminate guidewire retention by relying on the guidewire to unlock its contents (suture, suture holder, and antimicrobial dressings) in order to complete the procedure (46). In a forced error randomized controlled simulation study, this technology proved effective in preventing such events (36).…”

Section: Discussionmentioning

confidence: 99%

Patient, Operator, and Procedural Characteristics of Guidewire Retention as a Complication of Vascular Catheter Insertion

Kassis

Alkukhun

Kravitz

et al. 2023

Critical Care Explorations

View full text Add to dashboard Cite

OBJECTIVES: Guidewire retention after intravascular catheter insertion is considered a "never event. " Prior reports attribute this complication to various characteristics including uncooperative patients, operator inexperience, off-hour or emergent insertion, and underutilization of ultrasound guidance. In this descriptive analysis of consecutive events, we assessed the frequency of patient, operator, and procedural factors in guidewire retention. DESIGN:Pre-specified observational analysis as part of a quality improvement study of consecutive guidewire retention events across a multihospital health system from August 2007 to October 2015.

show abstract

Section: Discussionmentioning

confidence: 99%

Patient, Operator, and Procedural Characteristics of Guidewire Retention as a Complication of Vascular Catheter Insertion

Kassis

Alkukhun

Kravitz

et al. 2023

Critical Care Explorations

View full text Add to dashboard Cite

show abstract

An early economic evaluation of WireSafe™ to prevent guidewire retention in central venous catheter procedures

Mattock,

Hanbury,

Morys-Edge

et al. 2024

Journal of Patient Safety and Risk Management

View full text Add to dashboard Cite

Background Guidewire retention (GWR) poses a patient safety risk during Central Venous Catheter (CVC) insertions and is listed as a ‘Never Event’ by the National Health Service England (NHSE). WireSafe™ is an intervention to prevent GWR, but its cost-effectiveness is uncertain. This study is an early economic evaluation comparing WireSafe™ to standard care from a UK healthcare perspective. Methods We conducted (i) a primary analysis of GWR related NHSE Never Events data in England between 2016 and 2020; and (ii) a cost-utility analysis, including healthcare costs and quality-adjusted life years (QALYS) for populations receiving CVC-insertions. We applied a cost-effectiveness threshold of £30,000 per QALY and considered three WireSafe™ costing scenarios (£18.50, £4.50, and £2.50). Results NHSE Never Events data showed 61 GWR cases, averaging 1 per month. Most incidents (92%) were identified during hospital stays, with one serious adverse outcome reported (peri-arrest). In a population of 200,000, we estimate WireSafe™ would prevent 59.92 wire retentions, 5.61 procedural adverse events, 0.3 cardiac adverse events, and 0.19 deaths, improving QALYs by 4.87. In the base case analysis WireSafe™ was not cost-effective and had an economically justifiable price of £2.44. There were high levels of uncertainty in the lowest cost-scenario (ICER 95% credible interval: Dominant; £793,398). Conclusions The health benefits of WireSafe™ are limited due to low GWR rates and high identification rates, making WireSafe™ viable only at low costs. Future research should prioritise obtaining more precise estimates of these parameter values which are key determinants of cost-effectiveness.

show abstract

The WireSafe™ for Preventing Retained Central Venous Catheter Guidewires: Clinical Usability

Cited by 2 publications

References 9 publications

Patient, Operator, and Procedural Characteristics of Guidewire Retention as a Complication of Vascular Catheter Insertion

Patient, Operator, and Procedural Characteristics of Guidewire Retention as a Complication of Vascular Catheter Insertion

An early economic evaluation of WireSafe™ to prevent guidewire retention in central venous catheter procedures

Contact Info

Product

Resources

About